FXC:LSE:LSE-iShares China Large Cap UCITS (GBX)

ETF | Others |

Last Closing

USD 6776.5

Change

+40.50 (+0.60)%

Market Cap

N/A

Volume

0.02M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-30 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

-4.75 (-2.49%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

-0.84 (-0.70%)

USD 618.20B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.08 (-0.45%)

USD 572.76B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.05 (-0.38%)

USD 572.76B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

-0.25 (-0.35%)

USD 266.08B
0QZO:LSE 0QZO

-1.05 (-1.09%)

USD 258.54B
0QZ3:LSE Qualcomm Inc.

-4.82 (-2.77%)

USD 202.26B
PRJU:LSE Amundi Index Solutions - Amund..

-0.12 (-0.38%)

USD 200.79B
0R24:LSE Intel Corp.

-0.35 (-1.47%)

USD 196.14B

ETFs Containing FXC:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 25.43% 94% A 87% B+
Dividend Return 0.04% 32% F 43% F
Total Return 25.47% 93% A 87% B+
Trailing 12 Months  
Capital Gain 10.95% 40% F 47% F
Dividend Return 0.03% 26% F 33% F
Total Return 10.98% 38% F 46% F
Trailing 5 Years  
Capital Gain -25.30% 9% A- 22% F
Dividend Return 0.02% 9% A- 9% A-
Total Return -25.28% 8% B- 21% F
Average Annual (5 Year Horizon)  
Capital Gain -10.35% N/A N/A 13% F
Dividend Return -10.35% N/A N/A 13% F
Total Return 0.00% N/A N/A 6% D-
Risk Return Profile  
Volatility (Standard Deviation) 12.76% N/A N/A 70% C-
Risk Adjusted Return -81.07% N/A N/A 8% B-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike